First Opinion By Nathan Yates I have spinal muscular atrophy. Critics of the $2 million new gene therapy are missing the point
A STAT Investigation By Charles Piller Failure to warn: Hundreds died while taking an arthritis drug, but nobody alerted patients
Health By Christina Jewett — Kaiser Health News Drug used to halt puberty in children may cause lasting health problems
Health By Matthew Herper Eli Lilly says its monoclonal antibody cocktail is effective in treating Covid-19
Special Report By Lev Facher Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
Business By Rebecca Robbins Anxious about a big speech? This startup wants to calm you down — with a cardiac drug you pop like a mint
First Opinion By Vanila Singh Misguided federal regulations are likely to cause more pain in people already living with it
Biotech By Adam Feuerstein The biotech scorecard for the first quarter: 17 stock-moving events to watch
Pharmalot By Ed Silverman HHS rebukes drug makers for curtailing discounts to hospitals that serve low-income populations
First Opinion By Stephen Northrup Looking back and looking ahead: Vioxx, drug safety, and the legacy of Sen. Michael Enzi
Adam's Take By Adam Feuerstein Kulkarni victorious in best biopharma CEO vote; Leschly tops worst list
Pharmalot By Ed Silverman AbbVie wins 21 months of wrinkle-free competition for Botox thanks to an ITC ruling
Pharmalot By Ed Silverman Opioid prescribing has dropped dramatically since 2011, but experts say there’s ‘more to go’
Biotech By Adam Feuerstein and Matthew Herper AstraZeneca to acquire Alexion for $39 billion, adding blockbuster immune medicines
First Opinion By Cecile Riboud In biopharma mergers and acquisitions, managing regulatory compliance early protects return on investment
Pharmalot By Ed Silverman Supreme Court upholds controversial Arkansas law that regulates pharmacy benefit managers
Pharmalot By Ed Silverman Florida finds pharmacy benefit managers are benefiting from a lucrative profit center
Biotech By Adam Feuerstein J&J’s CAR-T drug maintains strong efficacy in myeloma, shaded by neurotoxicity
First Opinion By Giovanni Caforio The U.S. must support access to care and incentives for the innovation that transforms it
Biotech By Eric Boodman ‘How are we going to get on that plane?’: The transatlantic race to deliver CAR-T cancer therapy during the pandemic
Health Tech By Erin Brodwin How Amazon Pharmacy could ramp up pressure on the prescription drug industry
Pharmalot By Ed Silverman Federal authorities issue strong warning to pharma over speaker programs and kickbacks
Pharmalot By Ed Silverman Major generic makers will partner with Medicines Patent Pool to pursue voluntary licenses for Covid-19 drugs